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260Amplatzer vascular plug for occlusion or ﬂow
reduction of hemodialysis arteriovenous access
Pierre Bourquelot, MD,a Lamisse Karam, MD,a Alain Raynaud, MD,b Bernard Beyssen, MD,b and
Jean-Baptiste Ricco, MD, PhD,c Paris and Poitiers, France
Objective: Use of the Amplatzer vascular plug (AVP; St. Jude Medical Inc, St. Paul, Minn) for percutaneous occlusion of
a hemodialysis arteriovenous access (AVA) is an emerging practice, and only a few reports by radiologists have been
published. We report here a multidisciplinary experience of this technique not only for AVA occlusion but also for ﬂow
reduction in selected patients.
Methods: This preliminary study includes a series of 20 plugs of different generations (I, II, and IV) used in 19 hemo-
dialysis patients (two children, 17 adults). Of these, 15 AVAs were autologous ﬁstulas located at the elbow, 4 were
autologous forearm ﬁstulas, and 1 was a brachial-basilic polytetraﬂuoroethylene graft. AVP deployment was through
a 4F to 8F sheath, with oversizing from 30% to 50% to reduce the risk of migration. AVA occlusion (n[ 14), by placing
the AVP in the vein at its origin, was performed for central vein occlusion after unsuccessful percutaneous recanalization
(n[ 4), high ﬂow (n[ 2), hand ischemia (n[ 3), successful kidney transplant (n[ 1), and brachial-basilic or brachial-
brachial ﬁstula second-stage superﬁcialization technical failure (n [ 4). Vein/polytetraﬂuoroethylene grafts were not
removed. AVA ﬂow reduction (n [ 6), by placing the AVP in the radial artery, was performed for well-tolerated high
ﬂow (n [ 3) or high ﬂow associated with distal ischemia (n [ 3). All patients underwent a postoperative evaluation at
6-month intervals that included a clinical examination and duplex scan.
Results: AVA occlusion or ﬂow reduction was successfully achieved in all patients. Ischemia persisted in one patient and
a revascularization with a distal bypass was necessary. Mean follow-up was 1.2 6 0.8 years (range, 2 months-2.9 years).
No plug migration, access revascularization, or other complication was observed.
Conclusions: The results of this short preliminary study suggest that plug insertion for occlusion or for ﬂow reduction in
a hemodialysis AVA constitutes a reasonable alternative to coil insertion or to open surgery in selected patients. (J Vasc
Surg 2014;59:260-3.)Percutaneous vascular occlusion of hemodialysis ﬁstulas
using an Amplatzer vascular plug (AVP; St. Jude Medical
Inc, St. Paul, Minn) has recently been described only by
interventional vascular radiologists.1 This report docu-
ments our early surgical and radiologic experience with
20 devices in 19 selected patients for whom AVP place-
ment, not only for ﬁstula occlusion but also for ﬂow reduc-
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This study was conducted with the approval of the
Institutional Review Board and after obtaining informed
consent. All procedures were decided on a multidisciplinary
basis and performed under local anesthesia in an outpatient
setting.
Patients. Between February 2010 and December
2012, 19 consecutive patients received 20 AVPs to
occlude or to reduce the ﬂow (Tables I and II) of a
hemodialysis arteriovenous access (AVA; Fig 1). Patients
had a mean age of 58 6 33 years (range, 13-87 years),
and the AVAs were a mean age of 3.5 years (range, 96
days-14 years). Fifteen AVAs were autologous ﬁstulas at
the elbow, of which four were brachial-brachial, two were
radial-basilic, and nine were brachial-basilic ﬁstulas. Four
AVAs were autologous radiocephalic ﬁstulas in the wrist,
and one AVA was an upper arm polytetraﬂuoroethylene
graft. Vein/polytetraﬂuoroethylene grafts were not re-
moved during or after the AVP procedure.
An AVP was used to occlude the access at its origin
in 14 patients (Tables I and II). The reasons for AVA
occlusion were kidney transplantation in two, impossible
second-stage brachial vein superﬁcialization due to major
Table I. Patients, indications, and outcomes: A, Access occlusion by plug placement in the juxta-anastomotic vein/
polytetraﬂuoroethylene (PTFE) access in 14 patientsa
Plug,
No.
Patient
age, years
Access age,
years Access type Indication
Plug
generation
Device
diameter, mm
Follow-up,
years
1 77 2.48 Brachial-basilic AVF Central vein occlusion II 10 0.91
2 77 12.82 Brachial-basilic AVF Central vein occlusion II 16 0.23
3 83 1.07 Brachial-basilic AVF Central vein occlusion I 12 1.94
4 42 0.78 Brachial-brachial AVF Central vein occlusion II 10 2.22
5 66 0.76 Brachial-basilic AVF High ﬂow IV 6 2.91
6 81 7.41 Brachial-axillary PTFE High ﬂow I 16 1.21
7 51 0.50 Brachial-basilic AVF 2nd-stage superﬁcialization failure II 10 0.60
8 48 0.27 Brachial-brachial AVF 2nd-stage superﬁcialization failure II 12 0.08
9 62 0.54 Brachial-brachial AVF 2nd-stage superﬁcialization failure II 12 2.58
10 29 1.16 Brachial-brachial AVF 2nd-stage superﬁcialization failure I 12 0.19
11 76 0.28 Brachial-basilic AVF Ischemia II 10 1.00
12 51 0.28 Brachial-basilic AVF Ischemia II 10 1.85
13 80 1.25 Brachial-basilic AVF Ischemia I 12 0.31
14 15 6.41 Radial-cephalic AVF Kidney transplant I 10 0.07
AVF, Arteriovenous ﬁstula.
aNo complications were reported in this series.
Table II. Patients, indications, and outcomes: B, Flow reduction by plug placement in the juxta-anastomotic artery in six
patients
Plug,
No.
Patient
age, years
Access age,
years Access type Indication
Plug
generation
Device
diameter,
mm
Flow
reduction,
% Complications
Follow-up,
years
15 55 8.92 Radial-basilic AVF High ﬂow I 14 50 No 0.14
16 13 4.11 Radial-basilic AVF High ﬂow II 12 26 No 1.69
17 14 2.72 Radial-basilic AVF High ﬂow IV 8 43 No 0.67
18 60 2.56 Radial-cephalic
AVF
Ischemia IV 4 NA Persisting ischemia,
distal arterial bypass
1.50
19 74 2.31 Radial-cephalic
AVF
Ischemia IV 6 NA No 0.99
20 89 0.26 Radial-cephalic
AVF
Ischemia IV 6 NA No 0.56
AVF, Arteriovenous ﬁstula; NA, not available.
Fig 1. Technique of percutaneous plug occlusion of a hemodial-
ysis arteriovenous ﬁstula.
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central vein occlusion after unsuccessful percutaneous
recanalization in four, high ﬂow in two, and hand ischemia
in three.An AVP was used to reduce the ﬂow in the ﬁstula by
occluding the radial artery immediately distal or proximal
to the radial cephalic ﬁstula in six patients (Tables I and
II). In three of these patients, a wrist ﬁstula was com-
plicated by distal ischemia, and they were treated by
occluding the radial artery immediately distal to the ﬁstula
to suppress retrograde ﬂow in the distal radial artery and to
increase ulnar and digital arterial pressures. Three AVPs
were delivered in two patients with early brachial artery
bifurcation who had an elbow radial cephalic ﬁstula compli-
cated by high ﬂow. In these cases, the ﬂow was reduced by
occluding the radial artery immediately proximal to the
ﬁstula (Fig 2).
No patients were receiving warfarin therapy, which
would not have been a contraindication for ﬁstula
occlusion because this technique does not necessitate artery
cannulation. Patients with large aneurysmal ﬁstulas that
needed to be removed were excluded from this study.
AVP deployment was performed with a 4F to 8F
sheath with oversizing from 30% to 50%, according to
the vessel diameter, to avoid the risk of plug migration
Fig 2. Percutaneous plug ﬂow reduction of a hemodialysis arteriovenous ﬁstula (AVF) in a 5-year-old child with
a preoperative ﬂow in the ﬁstula of 1.5 L/min. A, Angiography during the procedure shows an early bifurcation of the
brachial artery and the upper arm radial-basilic ﬁstula. B, Plug delivery in the radial artery proximal to the ﬁstula. C,
Vascular occlusion was completed, with reduction of the postoperative ﬂow to 0.95 L/min.
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required <15 minutes by holding pressure on the vein.
In this series, 20 plugs of different generations (I, II, IV)
and with different diameters (mean, 8.6 6 2.3 mm; range,
4-16 mm) were used (Tables I and II). All patients under-
went a postoperative evaluation at 6-month intervals,
including clinical examination and duplex scan. Mean
follow-up was 1.2 6 0.8 years (range, 2 months-2.9
years).
RESULTS
Technical success with AVA occlusion or ﬂow reduc-
tion, according to the patient indications, was observed
in all patients (Tables I and II). Hand ischemia persisted
in one patient and was relieved by a distal bypass. No
immediate or postoperative complications were reported.
No migration of the AVP, recanalization of the ﬁstula, or
AVP-related skin erosion was observed during follow-up.
In one patient, high ﬂow in the AVA returned after 12
months and was successfully treated by insertion of a second
plug in a new collateral arterial branch.
DISCUSSION
For arteriovenous ﬁstula occlusion at the elbow, simple
compression over the access to induce thrombosis or
simple ligation of the vein might induce the risks of venous
stump aneurysmal degeneration, clot formation with distalartery embolization, or persisting ﬂow in early vein collat-
erals. Open surgery with ligation of the AVA associated
with the resection of the juxta-artery vein dilatation is, at
times, technically demanding, especially at the level of the
brachial artery when multiple scars and ﬁbrosis secondary
to previous surgery, massive edema, or local skin necrosis
are present.
For arteriovenous ﬁstula ﬂow reduction at the elbow,
the open approach may also be difﬁcult in patients with
an unusual arterial anatomy such as a high bifurcation of
the brachial artery. A less invasive percutaneous procedure,
such as delivery of multiple coils or plug insertion, is
favored in these cases.
In the setting of large, high-ﬂow vessels, delivery of
multiple coils is associated with a signiﬁcant risk of migra-
tion, and deployment of a single vascular plug would
appear to be the preferred option. The plug can be recap-
tured and repositioned before ﬁnal detachment, thereby
allowing physicians to block the vessel with precision to
avoid persisting ﬂow in early vein collaterals and the risk
of artery stenosis.
This percutaneous procedure should be avoided in
patients with an infected AVA or in patients with large
aneurysmal dilatation of the vein, for which a surgical resec-
tion is required anyway.
This study has limitations due to the small number of
patients, the brevity of the follow-up interval, and the
lack of homogeneity of the indications, from occlusion
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 1 Bourquelot et al 263of a ﬁstula that is no longer used or not useful, to ﬂow
reduction in cases of distal ischemia or cardiac concerns.
However, the easiness of the technique and the absence
of observed complications are remarkable.
CONCLUSIONS
The results of this short preliminary study suggest that
AVP insertion for occlusion or for ﬂow reduction in hemo-
dialysis AVA constitutes a reasonable alternative to open
surgery or to coil insertion in selected patients.REFERENCES
1. GumusB. Percutaneous embolization of hemodialysis ﬁstulas byAmplatzer
vascular plug with midterm follow-up. J Vasc Interv Radiol 2011;22:
1581-5.
2. Bourquelot P, Gaudric J, Turmel-Rodrigues L, Franco G, Van Laere O,
Raynaud A. Proximal radial artery ligation (PRAL) for reduction of ﬂow
in autogenous radial cephalic accesses for haemodialysis. Eur J Vasc
Endovasc Surg 2010;40:94-9.Submitted Feb 24, 2013; accepted Jul 4, 2013.
